Common variants at 19p13 are associated with susceptibility to ovarian cancer

被引:205
作者
Bolton, Kelly L. [1 ,2 ]
Tyrer, Jonathan [1 ]
Song, Honglin [1 ]
Ramus, Susan J. [3 ]
Notaridou, Maria [3 ]
Jones, Chris [3 ]
Sher, Tanya [3 ]
Gentry-Maharaj, Aleksandra [3 ]
Wozniak, Eva
Tsai, Ya-Yu [4 ]
Weidhaas, Joanne [5 ]
Paik, Daniel [6 ]
Van den Berg, David J. [7 ]
Stram, Daniel O. [7 ]
Pearce, Celeste Leigh [7 ]
Wu, Anna H. [7 ]
Brewster, Wendy [8 ]
Anton-Culver, Hoda [8 ]
Ziogas, Argyrios [8 ]
Narod, Steven A. [9 ]
Levine, Douglas A. [10 ]
Kaye, Stanley B. [11 ]
Brown, Robert [12 ]
Paul, Jim [13 ]
Flanagan, James [12 ]
Sieh, Weiva [14 ]
McGuire, Valerie [14 ]
Whittemore, Alice S. [14 ]
Campbell, Ian [16 ]
Gore, Martin E. [16 ]
Lissowska, Jolanta [17 ,18 ]
Yang, Hanna P. [2 ]
Medrek, Krzysztof [19 ]
Gronwald, Jacek [19 ]
Lubinski, Jan [19 ]
Jakubowska, Anna [19 ]
Le, Nhu D. [20 ]
Cook, Linda S. [21 ,22 ]
Kelemen, Linda E. [22 ]
Brook-Wilson, Angela [23 ,24 ]
Massuger, Leon F. A. G. [25 ]
Kiemeney, Lambertus A. [2 ]
Aben, Katja K. H. [26 ]
van Altena, Anne M. [25 ]
Houlston, Richard [27 ]
Tomlinson, Ian [28 ]
Palmieri, Rachel T. [29 ]
Moorman, Patricia G. [29 ]
Schildkraut, Joellen [29 ]
Iversen, Edwin S. [30 ]
机构
[1] Univ Cambridge, Dept Oncol, Cambridge, England
[2] Natl Canc Inst, Natl Inst Hlth, Div Canc Epidemiol & Genet, Rockville, MD USA
[3] UCL, Inst Womens Hlth, Dept Gynecol Oncol, EGA, London, England
[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[5] Yale Univ, Dept Therapeut Radiol, New Haven, CT 06510 USA
[6] Yale Univ, Dept Obstet & Gynecol, New Haven, CT USA
[7] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA
[8] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA
[9] Ctr Res Womens Hlth, Toronto, ON, Canada
[10] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA
[11] Inst Canc Res, Med Sect, Sutton, Surrey, England
[12] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England
[13] Univ Glasgow, Canc Res UK Clin Trials Unit, Glasgow, Lanark, Scotland
[14] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA
[15] Peter MacCallum Canc Inst, Melbourne, Australia
[16] Royal Marsden Hosp, Gynecol Oncol Unit, London SW3 6JJ, England
[17] Inst Oncol, Warsaw, Poland
[18] M Sklodowska Curie Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland
[19] Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland
[20] British Columbia Canc Agcy, Canc Control Res, Vancouver, BC V5Z 4E6, Canada
[21] Univ New Mexico, Div Epidemiol & Biostatist, Albuquerque, NM 87131 USA
[22] Alberta Hlth Serv Canc Care, Calgary, AB, Canada
[23] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada
[24] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada
[25] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Gynaecol, Nijmegen, Netherlands
[26] Comprehens Canc Ctr E, Nijmegen, Netherlands
[27] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England
[28] Wellcome Trust Ctr Human Genet, Populat & Funct Genet Lab, Oxford, England
[29] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC USA
[30] Duke Univ, Dept Stat, Durham, NC USA
[31] Mayo Clin Coll Med, Dept Hlth Sci Res, Rochester, MN USA
[32] Mayo Clin Coll Med, Dept Lab Med & Pathol, Rochester, MN USA
[33] Danish Canc Soc, Dept Virus, Copenhagen, Denmark
[34] Danish Canc Soc, Canc Inst Canc Epidemiol, Canc Inst Canc Epidemiol, Copenhagen, Denmark
[35] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
[36] Juliane Marie Ctr, Gynaecol Clin, Copenhagen, Denmark
[37] Cedars Sinai Med Ctr, Womens Canc Res Inst, Samuel Oschin Comprehens Canc Ctr, Los Angeles, CA 90048 USA
[38] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA
[39] Magee Womens Hosp, Pittsburgh, PA USA
[40] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA
[41] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA
[42] Brown Univ, Dept Obstet & Gynecol, Providence, RI 02912 USA
[43] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA
[44] Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Helsinki, Finland
[45] Byelorussian Inst Oncol & Med Radiol Aleksandro, Minsk, BELARUS
[46] Hannover Med Sch, Clin Obstet & Gynaecol, D-3000 Hannover, Germany
[47] Friedrich Schiller Univ, Clin Obstet & Gynaecol, Jena, Germany
[48] Univ Hawaii, Canc Res Ctr Hawaii, Honolulu, HI 96813 USA
[49] Univ Ulm, Dept Obstet & Gynecol, Ulm, Germany
[50] Deutsch Krebsforschungszentrum, Div Canc Epidemiol, Unit Genet Epidemiol, D-6900 Heidelberg, Germany
基金
英国医学研究理事会; 英国惠康基金;
关键词
GENOME-WIDE ASSOCIATION; BRCA1; COMPLEX;
D O I
10.1038/ng.666
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Epithelial ovarian cancer (EOC) is the leading cause of death from gynecological malignancy in the developed world, accounting for 4% of the deaths from cancer in women(1). We performed a three-phase genome-wide association study of EOC survival in 8,951 individuals with EOC (cases) with available survival time data and a parallel association analysis of EOC susceptibility. Two SNPs at 19p13.11, rs8170 and rs2363956, showed evidence of association with survival (overall P = 5 x 10(-4) and P = 6 x 10(-4), respectively), but they did not replicate in phase 3. However, the same two SNPs demonstrated genome-wide significance for risk of serous EOC (P = 3 x 10(-9) and P = 4 x 10(-11), respectively). Expression analysis of candidate genes at this locus in ovarian tumors supported a role for the BRCA1-interacting gene C19orf62, also known as MERIT40, which contains rs8170, in EOC development.
引用
收藏
页码:880 / +
页数:7
相关论文
共 24 条
[11]  
Hindorff L., 2010, CATALOG PUBLISHED GE
[12]   A set of BAC clones spanning the human genome [J].
Krzywinski, M ;
Bosdet, I ;
Smailus, D ;
Chiu, R ;
Mathewson, C ;
Wye, N ;
Barber, S ;
Brown-John, M ;
Chan, S ;
Chand, S ;
Cloutier, A ;
Girn, N ;
Lee, D ;
Masson, A ;
Mayo, M ;
Olson, T ;
Pandoh, P ;
Prabhu, AL ;
Schoenmakers, E ;
Tsai, M ;
Albertson, D ;
Lam, W ;
Choy, CO ;
Osoegawa, K ;
Zhao, SY ;
de Jong, PJ ;
Schein, J ;
Jones, S ;
Marra, MA .
NUCLEIC ACIDS RESEARCH, 2004, 32 (12) :3651-3660
[13]   Pathology of ovarian cancers in BRCA1 and BRCA2 carriers [J].
Lakhani, SR ;
Manek, S ;
Penault-Llorca, F ;
Flanagan, A ;
Arnout, L ;
Merrett, S ;
McGuffog, L ;
Steele, D ;
Devilee, P ;
Klijn, JGM ;
Meijers-Heijboer, H ;
Radice, P ;
Pilotti, S ;
Nevanlinna, H ;
Butzow, R ;
Sobol, H ;
Jacquemier, J ;
Lyonet, DS ;
Neuhausen, SL ;
Weber, B ;
Wagner, T ;
Winqvist, R ;
Bignon, YJ ;
Monti, F ;
Schmitt, F ;
Lenoir, G ;
Seitz, S ;
Hamman, U ;
Pharoah, P ;
Lane, G ;
Ponder, B ;
Bishop, DT ;
Easton, DF .
CLINICAL CANCER RESEARCH, 2004, 10 (07) :2473-2481
[14]   A modified medium that significantly improves the growth of human normal ovarian surface epithelial (OSE) cells in vitro [J].
Li, NFF ;
Wilbanks, G ;
Balkwill, F ;
Jacobs, IJ ;
Dafou, D ;
Gayther, SA .
LABORATORY INVESTIGATION, 2004, 84 (07) :923-931
[15]   Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast [J].
Maia, Ana-Teresa ;
Spiteri, Inmaculada ;
Lee, Alvin J. X. ;
O'Reilly, Martin ;
Jones, Linda ;
Caldas, Carlos ;
Ponder, Bruce A. J. .
BREAST CANCER RESEARCH, 2009, 11 (06)
[16]   Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinoma [J].
Majdak, EJ ;
Debniak, J ;
Milczek, T ;
Cornelisse, CJ ;
Devilee, P ;
Emerich, J ;
Jassem, J ;
De Bock, GH .
CANCER, 2005, 104 (05) :1004-1012
[17]   A new multipoint method for genome-wide association studies by imputation of genotypes [J].
Marchini, Jonathan ;
Howie, Bryan ;
Myers, Simon ;
McVean, Gil ;
Donnelly, Peter .
NATURE GENETICS, 2007, 39 (07) :906-913
[18]   Estimating local ancestry in admixed populations [J].
Sankararaman, Sriram ;
Sridhar, Srinath ;
Kimmel, Gad ;
Halperin, Eran .
AMERICAN JOURNAL OF HUMAN GENETICS, 2008, 82 (02) :290-303
[19]   A fast and flexible statistical model for large-scale population genotype data: Applications to inferring missing genotypes and haplotypic phase [J].
Scheet, P ;
Stephens, M .
AMERICAN JOURNAL OF HUMAN GENETICS, 2006, 78 (04) :629-644
[20]   MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks [J].
Shao, Genze ;
Patterson-Fortin, Jeffrey ;
Messick, Troy E. ;
Feng, Dan ;
Shanbhag, Niraj ;
Wang, Yingqun ;
Greenberg, Roger A. .
GENES & DEVELOPMENT, 2009, 23 (06) :740-754